secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tyra Biosciences, Inc. (TYRA)
CIK:        0001863127
Form:       8-K
Filed at:   2024-05-31T23:59:59+00:00
Accession:  0001193125-24-151705
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.03, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tyra Biosciences shareholders approve officer exculpation amendment to charter
------------------------------------------------------------------------------

- Amendment eliminates personal liability of officers for monetary damages for breach of fiduciary duty under Delaware law.
- Three Class III directors elected: Melissa McCracken, Jake Simson, Rehan Verjee.
- Ratification of Ernst & Young as independent auditor for fiscal year ending December 31, 2024.
- Amendment effective upon filing with Delaware Secretary of State on May 29, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1863127/000119312524151705/0001193125-24-151705-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1863127/000119312524151705/d807421d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-151705

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer